Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 65
Filtrar
1.
Jt Comm J Qual Patient Saf ; 49(12): 671-679, 2023 12.
Artículo en Inglés | MEDLINE | ID: mdl-37748938

RESUMEN

BACKGROUND: Sexual boundary violations in the health care setting cause harm for victims, threaten an organization's culture, and create extraordinary organizational risk. The inherent complexities of health care organizations present unique challenges for the initial triage and response to reports of alleged violations. METHODS: A group of experts with experience in law, leadership, human resources, medicine, and health care operations identified processes for organizations to triage and implement an early response to allegations of sexual boundary violations. The group reviewed a series of 100 reports of alleged violations described by patients and coworkers from a 200-hospital professional accountability collaborative to identify the elements of an ideal initial triage and management approach. RESULTS: The group identified three domains to guide early triage and response to reports of boundary violations: (1) severity and acuity of the alleged violation; (2) roles and relationship(s) of the complainant, respondent, and other affected individuals; and (3) contextual information such as prior activity or other mitigating factors. The group identified leadership engagement; coordinated responses; clear articulation of values, policies, and procedures; aligned data reporting; thoughtful reviews; and securing appropriate resources as essential elements of an organization's response. CONCLUSION: A structured systematic approach to classify and respond to allegations of sexual boundary violation is described. The initial response should be guided by assessment of the severity and timing of the reported behavior, followed by assessment of roles and responsibilities with involvement of all relevant stakeholders. Contextual issues and special circumstances of relevance should be identified and incorporated into the response. Systems to identify, store, and retrieve behavior of concern should be improved and integrated.


Asunto(s)
Atención a la Salud , Hospitales , Humanos , Triaje , Liderazgo
2.
PLoS One ; 18(6): e0285584, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-37384788

RESUMEN

BACKGROUND: Acute benzodiazepine withdrawal has been described, but literature regarding the benzodiazepine-induced neurological injury that may result in enduring symptoms and life consequences is scant. OBJECTIVE: We conducted an internet survey of current and former benzodiazepine users and asked about their symptoms and adverse life events attributed to benzodiazepine use. METHODS: This is a secondary analysis of the largest survey ever conducted with 1,207 benzodiazepine users from benzodiazepine support groups and health/wellness sites who completed the survey. Respondents included those still taking benzodiazepines (n = 136), tapering (n = 294), or fully discontinued (n = 763). RESULTS: The survey asked about 23 specific symptoms and more than half of the respondents who experienced low energy, distractedness, memory loss, nervousness, anxiety, and other symptoms stated that these symptoms lasted a year or longer. These symptoms were often reported as de novo and distinct from the symptoms for which the benzodiazepines were originally prescribed. A subset of respondents stated that symptoms persisted even after benzodiazepines had been discontinued for a year or more. Adverse life consequences were reported by many respondents as well. LIMITATIONS: This was a self-selected internet survey with no control group. No independent psychiatric diagnoses could be made in participants. CONCLUSIONS: Many prolonged symptoms subsequent to benzodiazepine use and discontinuation (benzodiazepine-induced neurological dysfunction) have been shown in a large survey of benzodiazepine users. Benzodiazepine-induced neurological dysfunction (BIND) has been proposed as a term to describe symptoms and associated adverse life consequences that may emerge during benzodiazepine use, tapering, and continue after benzodiazepine discontinuation. Not all people who take benzodiazepines will develop BIND and risk factors for BIND remain to be elucidated. Further pathogenic and clinical study of BIND is needed.


Asunto(s)
Amnesia , Ansiedad , Humanos , Trastornos de Ansiedad , Grupos Control , Benzodiazepinas/efectos adversos
3.
Ther Adv Psychopharmacol ; 13: 20451253221145561, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-36760692

RESUMEN

Introduction: Benzodiazepine tapering and cessation has been associated with diverse symptom constellations of varying duration. Although described in the literature decades ago, the mechanistic underpinnings of enduring symptoms that can last months or years have not yet been elucidated. Objective: This secondary analysis of the results from an Internet survey sought to better understand the acute and protracted withdrawal symptoms associated with benzodiazepine use and discontinuation. Methods: An online survey (n = 1207) was used to gather information about benzodiazepine use, including withdrawal syndrome and protracted symptoms. Results: The mean number of withdrawal symptoms reported by a respondent in this survey was 15 out of 23 symptoms. Six percent of respondents reported having all 23 listed symptoms. A cluster of least-frequently reported symptoms (whole-body trembling, hallucinations, seizures) were also the symptoms most frequently reported as lasting only days or weeks, that is, short-duration symptoms. Symptoms of nervousness/anxiety/fear, sleep disturbances, low energy, and difficulty focusing/distractedness were experienced by the majority of respondents (⩾85%) and, along with memory loss, were the symptoms of longest duration. Prolonged symptoms of anxiety and insomnia occurred in many who have discontinued benzodiazepines, including over 50% who were not originally prescribed benzodiazepines for that indication. It remains unclear if these symptoms might be caused by neuroadaptive and/or neurotoxic changes induced by benzodiazepine exposure. In this way, benzodiazepine withdrawal may have acute and long-term symptoms attributable to different underlying mechanisms, which is the case with alcohol withdrawal. Conclusions: These findings tentatively support the notion that symptoms which are acute but transient during benzodiazepine tapering and discontinuation may be distinct in their nature and duration from the enduring symptoms experienced by many benzodiazepine users.

5.
Waste Manag ; 83: 68-78, 2019 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-30514473

RESUMEN

A controlled release test was carried out to assess the accuracy of the tracer gas dispersion method, which is used to measure whole-site landfill methane (CH4) emissions as well as fugitive emissions from other area sources. Two teams performed measurements using analytical instruments installed in two vehicles, to measure downwind concentrations of target (CH4) and tracer gases at distances of 1.2-3.5 km from the release locations. The controlled target gas release rates were either 5.3 or 10.9 kg CH4 h-1, and target and tracer gases were released at distances between 12 m and 140 m from each other. Five measurement campaigns were performed, where the plume was traversed between 2 and 31 times. The measured target gas emissions agreed well with the controlled releases, with rate differences no greater than 1.1 kg CH4 h-1 for Team A and 1.0 kg CH4 h-1 for Team B when quantifying a controlled release of 10.9 kg CH4 h-1. This corresponds to a maximum error of ±10%. A larger error of up to 18% was seen in the campaign with a lower target gas release rate (5.3 kg CH4 h-1). Using a cross plume integration method to calculate tracer gas to target gas ratios provided the most accurate results (lowest error), whereas larger errors (up to 49%) were observed when using other calculation methods. By establishment of an error budget and comparison with the measured error based on the release test, it could be concluded that following best practice when performing measurements, the overall error of a tracer gas dispersion measurement is very likely to be less than 20%.


Asunto(s)
Contaminantes Atmosféricos , Eliminación de Residuos , Monitoreo del Ambiente , Gases , Metano , Instalaciones de Eliminación de Residuos
6.
Environ Pollut ; 240: 938-949, 2018 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-29949845

RESUMEN

Demand for groundwater in urban centres across Asia continues to rise with ever deeper wells being drilled to avoid shallow contamination. The vulnerability of deep alluvial aquifers to contaminant migration is assessed in the ancient city of Varanasi, India, using a novel combination of emerging organic contaminants (EOCs) and groundwater residence time tracers (CFC and SF6). Both shallow and intermediate depth private sources (<100 m) and deep (>100 m) municipal groundwater supplies were found to be contaminated with a range of EOCs including pharmaceuticals (e.g. sulfamethoxazole, 77% detection frequency, range <0.0001-0.034 µg L-1), perfluoroalkyl substances (e.g. PFOS, range <0.0001-0.033 µg L-1) as well as a number of pesticides (e.g. phenoxyacetic acid, range <0.02-0.21 µg L-1). The profile of EOCs found in groundwater mirror those found in surface waters, albeit at lower concentrations, and reflect common waste water sources with attenuation in the subsurface. Mean groundwater residence times were found to be comparable between some deep groundwater and shallow groundwater sources with residence times ranging from >70 to 30 years. Local variations in aquifer geology influence the extent of modern recharge at depth. Both tracers provide compelling evidence of significant inputs of younger groundwater to depth >100 m within the aquifer system.


Asunto(s)
Monitoreo del Ambiente , Agua Subterránea/química , Compuestos Orgánicos/análisis , Contaminantes Químicos del Agua/análisis , Asia , Ciudades , India , Plaguicidas/análisis , Aguas Residuales
8.
Expert Rev Clin Pharmacol ; 9(2): 329-38, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-26582317

RESUMEN

BACKGROUND AND AIMS: vitamin D deficiency (25-hydroxyvitamin D) affects over one billion people worldwide. Vitamin D deficiency results in progression of osteoporosis as well as other conditions. Previous studies have shown high rates of vitamin D deficiency in Pakistan despite appreciable levels of sunshine. However, none have assessed vitamin D deficiency across all age groups, genders, incomes, and locations to guide future strategies. METHODS: Questionnaire and blood sampling among 4830 randomly selected citizens. RESULTS: High levels of deficiency among all age groups, genders, income levels, and locations. Amongst the selected citizens, 53.5% had vitamin D deficiency, 31.2% had insufficient vitamin D, and only 15.3% normal vitamin D. CONCLUSION: High rates of vitamin D deficiency in Pakistan despite high levels of sunshine and previous Food Acts asking for food fortification with vitamin D. Public health strategies are needed to address high deficiency rates, including food fortification, i.e. nurture, alongside increasing exposure to sunlight, i.e. nature. This will involve all key stakeholder groups.


Asunto(s)
Luz Solar , Deficiencia de Vitamina D/epidemiología , Vitamina D/análogos & derivados , Adulto , Anciano , Femenino , Alimentos Fortificados/provisión & distribución , Humanos , Masculino , Persona de Mediana Edad , Pakistán/epidemiología , Prevalencia , Encuestas y Cuestionarios , Vitamina D/sangre , Adulto Joven
9.
Am J Drug Alcohol Abuse ; 41(5): 367-70, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26186388

RESUMEN

Methadone and buprenorphine are highly effective and commonly prescribed for the treatment of opioid use disorder. Both medications are also efficacious for the treatment of pregnant women with this disorder. In one third of states, however, Medicaid reimbursement will cover the cost of buprenorphine, but not methadone, to treat opioid use disorder in pregnant women. This commentary will explore the clinical and policy rational and consequences of this policy, with the opinion that this approach is guided by political expediency rather than sound clinical research. The commentary will focus on the pharmacological management of prescription opioid dependence during pregnancy in Tennessee, one of the states that restrict Medicaid coverage of pregnant women to buprenorphine. Tennessee is also relevant in that this state ranks second nationally in the rate of prescriptions written for opioid pain relievers; in contrast to injection opioid use in urban populations, opioid addiction in rural and southeastern regions of the US is characterized by use of non-injection prescription opioids. Until recently, most research-based recommendations for the management of opioid use disorder during pregnancy have derived from studies of women using opioids intravenously. The lack of research in non-injection opioid-using pregnant women may partially explain why policy rather than scientific evidence guides Medicaid reimbursement. It is hoped that future research in pregnant women addicted to prescription opioids will clarify which opioid addicted pregnant women have better outcomes with buprenorphine or methadone treatment and these findings, in turn, will inform Medicaid reimbursement.


Asunto(s)
Cobertura del Seguro/legislación & jurisprudencia , Medicaid , Tratamiento de Sustitución de Opiáceos/estadística & datos numéricos , Trastornos Relacionados con Opioides/tratamiento farmacológico , Política , Complicaciones del Embarazo/tratamiento farmacológico , Buprenorfina/uso terapéutico , Femenino , Humanos , Metadona/uso terapéutico , Tratamiento de Sustitución de Opiáceos/economía , Trastornos Relacionados con Opioides/economía , Embarazo , Complicaciones del Embarazo/economía , Tennessee , Estados Unidos
10.
Gen Hosp Psychiatry ; 36(6): 732-6, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-25085717

RESUMEN

OBJECTIVE: We compared fitness-for-duty assessment findings of physicians who subsequently engaged in suicidal behavior and those who did not. METHOD: Assessments of 141 physicians evaluated at the Vanderbilt Comprehensive Assessment Program were retrospectively compared between those who later either attempted (n = 2) or completed (n = 5) suicide versus the remainder of the sample. RESULTS: Subsequent suicidal behaviors were associated with being found unfit to practice (86% vs. 31%, P < .05), being in solo practice (71% vs. 33%) and chronically using benzodiazepines (57% vs. 11%, Fisher's Exact Test, P < .05). CONCLUSION: Being found unfit for practice may trigger a cascade of adverse social and financial consequences. Those engaged in solo practice may be particularly vulnerable due to isolation and lack of oversight by supportive colleagues. Finally, chronic benzodiazepine use may impair resilience due to associated brain dysfunction. Although these characteristics must be investigated prospectively, our observations suggest that they may be important signals of increased risk for suicidal behavior in physicians. The intense stress associated with medical practice and the relatively high rates of suicidal behavior among physicians make it important to be able to identify physicians who are at risk, so that appropriate preventive actions can be taken.


Asunto(s)
Evaluación del Rendimiento de Empleados/estadística & datos numéricos , Trastornos Mentales/epidemiología , Inhabilitación Médica/estadística & datos numéricos , Médicos/estadística & datos numéricos , Suicidio/estadística & datos numéricos , Adulto , Anciano , Femenino , Humanos , Masculino , Persona de Mediana Edad , Intento de Suicidio/estadística & datos numéricos
11.
Environ Sci Process Impacts ; 16(8): 1957-66, 2014 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-24933364

RESUMEN

The emission of carbon dioxide (CO2) from industrial sources is one of the main anthropogenic contributors to the greenhouse effect. Direct remote sensing of CO2 emissions using optical methods offers the potential for the identification and quantification of CO2 emissions. We report the development and demonstration of a ground based mobile differential absorption lidar (DIAL) able to measure the mass emission rate of CO2 in the plume from a power station. To our knowledge DIAL has not previously been successfully applied to the measurement of emission plumes of CO2 from industrial sources. A significant challenge in observing industrial CO2 emission plumes is the ability to discriminate and observe localised concentrations of CO2 above the locally observed background level. The objectives of the study were to modify our existing mobile infrared DIAL system to enable CO2 measurements and to demonstrate the system at a power plant to assess the feasibility of the technique for the identification and quantification of CO2 emissions. The results of this preliminary study showed very good agreement with the expected emissions calculated by the site. The detection limit obtained from the measurements, however, requires further improvement to provide quantification of smaller emitters of CO2, for example for the detection of fugitive emissions. This study has shown that in principle, remote optical sensing technology will have the potential to provide useful direct data on CO2 mass emission rates.


Asunto(s)
Contaminantes Atmosféricos/análisis , Dióxido de Carbono/análisis , Monitoreo del Ambiente/instrumentación , Tecnología de Sensores Remotos/instrumentación , Diseño de Equipo , Rayos Láser , Centrales Eléctricas , Emisiones de Vehículos/análisis
14.
Br J Cancer ; 110(5): 1322-7, 2014 Mar 04.
Artículo en Inglés | MEDLINE | ID: mdl-24448361

RESUMEN

BACKGROUND: Thyroid cancer incidence is increasing worldwide, but with large variations in incidence that may reflect either diagnostic bias or true ethnic differences. We sought to determine the effect of ethnicity on the incidence of thyroid cancer in England, a multiethnic population with a single health-care system. METHODS: We analysed 11,263 thyroid cancer registrations with ethnicity obtained by linkage to the Hospital Episodes Statistics database. Incidence rate ratios (RRs) adjusted for age, sex and income were calculated for the six main non-White ethnic groups in England compared with Whites and to each other. RESULTS: Thyroid cancer incidence was higher in all ethnic groups, except Indians, compared with Whites: in Pakistanis (RR 1.79, 99% floating confidence interval (FCI) 1.47-2.19); Bangladeshis (RR 1.99, 99% FCI 1.46-2.71); Black Africans (RR 1.69, 99% FCI 1.34-2.13); Black Caribbeans (RR 1.56, 99% FCI 1.25-1.93); and Chinese (RR 2.14, 99% FCI 1.63-2.80). CONCLUSION: The risk of thyroid cancer in England varies significantly by ethnicity. The elevated incidence in most ethnic minorities is unlikely to be due to diagnostic bias and warrants further investigation.


Asunto(s)
Neoplasias de la Tiroides/etnología , Neoplasias de la Tiroides/epidemiología , Inglaterra/epidemiología , Etnicidad , Femenino , Humanos , Incidencia , Masculino , Persona de Mediana Edad , Riesgo
15.
Gen Hosp Psychiatry ; 35(6): 659-63, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23910216

RESUMEN

OBJECTIVES: We compare findings from 10 years of experience evaluating physicians referred for fitness-to-practice assessment to determine whether those referred for disruptive behavior are more or less likely to be declared fit for duty than those referred for mental health, substance abuse or sexual misconduct. METHOD: Deidentified data from 381 physicians evaluated by the Vanderbilt Comprehensive Assessment Program (2001-2012) were analyzed and compared to general physician population data and also to previous reports of physician psychiatric diagnosis found by MEDLINE search. RESULTS: Compared to the physicians referred for disruptive behavior (37.5% of evaluations), each of the other groups was statistically significantly less likely to be assessed as fit for practice [substance use, %: odds ratio (OR)=0.22, 95% confidence interval (CI)=0.10-0.47, P<.001; mental health, %: OR=0.14, 95% CI=0.06-0.31, P<.001; sexual boundaries, %: OR=0.27, 95% CI=0.13-0.58, P=.001]. CONCLUSIONS: The number of referrals to evaluate physicians presenting with behavior alleged to be disruptive to clinical care increased following the 2008 Joint Commission guidelines that extended responsibility for professional conduct outside the profession itself to the institutions wherein physicians work. Better strategies to identify and manage disruptive physician behavior may allow those physicians to return to practice safely in the workplace.


Asunto(s)
Competencia Clínica/estadística & datos numéricos , Trastornos Mentales/epidemiología , Inhabilitación Médica/estadística & datos numéricos , Médicos/estadística & datos numéricos , Competencia Profesional/estadística & datos numéricos , Mala Conducta Profesional/estadística & datos numéricos , Trastornos Relacionados con Sustancias/epidemiología , Adulto , Anciano , Competencia Clínica/normas , Femenino , Humanos , Masculino , Persona de Mediana Edad , Oportunidad Relativa , Médicos/psicología , Competencia Profesional/normas
17.
Front Health Serv Manage ; 25(4): 3-11, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-19603686

RESUMEN

Physicians exhibiting a pattern of disruptive conduct represent a small portion of all healthcare professionals. Available evidence demonstrates, however, that their behaviors can result in increased workplace stress; contribute to poor workplace environments; contribute to dysfunctional teams; reduce quality of care for patients and families; and increase risk of litigation for hospitals and institutions. Our experience at Vanderbilt reveals that both internal and external factors play a role in a physician's behavior and ability to cope with workplace stresses. We have gained valuable insight into various means of indentifying, assessing, treating, and remediating physicians exhibiting unprofessional behavior. The vast majority of healthcare team members conduct themselves professionally and without complaint. This paper will demonstrate how to address those rare individuals who exhibit disruptive and/or unprofessional behavior.


Asunto(s)
Agresión , Administración de Personal/métodos , Médicos/normas , Humanos , Médicos/psicología , Estrés Psicológico
18.
Heart ; 94(5): 628-32, 2008 May.
Artículo en Inglés | MEDLINE | ID: mdl-17916663

RESUMEN

OBJECTIVE: To examine the long-term outcome of patients evaluated in a rapid assessment chest pain clinic (RACPC): are "low-risk" patients safely reassured? DESIGN: Retrospective cohort study. SETTING: Staff grade-led RACPC in an urban teaching hospital. PARTICIPANTS: 3378 patients (51% male), attending the RACPC between April 1996 and February 2000. MAIN OUTCOME MEASURES: Death, coronary mortality, morbidity and revascularisation over a median follow-up of 6 years. Coronary standardised mortality ratio (SMR). RESULTS: 2036 (60.3%) patients were categorised as "low risk", 957 (28.3%) as having "stable coronary artery disease" and 214 (6.3%) as being an "acute coronary syndrome". During the study, 3.6% of patients in the low risk category, 11.9% in the stable coronary artery disease category and 24.6% in the acute coronary syndrome category died from coronary artery disease or had a myocardial infarction. 5.5%, 18.2% and 18.4%, respectively, died from any cause. Compared to the local population (coronary SMR = 100), our "low risk/non-coronary chest pain" cohort had a coronary SMR of 51 (95% CI 31 to 83), the "stable coronary artery disease" cohort 240 (187 to 308) and the "acute coronary syndrome" cohort 780 (509 to 1196). CONCLUSION: The RACPC was effective at triaging patients with chest pain. Patients identified as at "low risk" were unlikely to have an adverse coronary outcome and were appropriately reassured.


Asunto(s)
Dolor en el Pecho/etiología , Enfermedad Coronaria/diagnóstico , Accesibilidad a los Servicios de Salud/normas , Anciano , Angina de Pecho/diagnóstico , Servicio de Cardiología en Hospital , Estudios de Cohortes , Femenino , Humanos , Masculino , Persona de Mediana Edad , Evaluación de Procesos y Resultados en Atención de Salud , Pronóstico , Derivación y Consulta/normas , Estudios Retrospectivos , Escocia , Análisis de Supervivencia , Resultado del Tratamiento
19.
Can J Psychiatry ; 52(5): 315-22, 2007 May.
Artículo en Inglés | MEDLINE | ID: mdl-17542382

RESUMEN

OBJECTIVE: This exploratory study compares objective personality test findings among physicians exhibiting different forms of misconduct. The importance of delineating distinctive personality characteristics by type of offence is that such characterizations can direct therapy and prognosis for remediation. METHOD: Eighty-eight physicians referred to the Vanderbilt Comprehensive Assessment Program for Professionals (V-CAP) completed the Minnesota Multiphasic Personality Inventory-2, the Personality Assessment Inventory, or both, as part of their evaluation. On the basis of referral information, physicians were partitioned into 3 groups of offenders: "sexual boundary violators," "behaviourally disruptive," and "other misconduct." RESULTS: On both personality measures, the sexual boundary violators generated the greatest percentage of profiles indicative of character pathology. CONCLUSIONS: Although all 3 groups exhibited unacceptable behaviours, the pervasive personality features of the sexual boundary violators are associated with greater therapeutic challenge, and these individuals likely pose the greater risk of reoffending.


Asunto(s)
MMPI , Inventario de Personalidad , Inhabilitación Médica/psicología , Mala Conducta Profesional/psicología , Adulto , Trastorno de la Conducta/diagnóstico , Trastorno de la Conducta/psicología , Femenino , Humanos , Masculino , Persona de Mediana Edad , Trastornos de la Personalidad/diagnóstico , Trastornos de la Personalidad/psicología , Psicometría , Factores de Riesgo , Prevención Secundaria , Delitos Sexuales/psicología
20.
Br J Cancer ; 96(11): 1747-9, 2007 Jun 04.
Artículo en Inglés | MEDLINE | ID: mdl-17453005

RESUMEN

Among 7182 women with endometrial cancer in Scotland, standardised mortality ratios (and 95% confidence intervals (CI)) were 6.38 (5.74-7.15) for all cancers and 1.10 (1.00-1.22) for circulatory diseases as underlying cause of death and 2.81 (2.19-3.70) for diabetes as underlying/contributory cause of death.


Asunto(s)
Carcinoma Endometrioide/complicaciones , Enfermedades Cardiovasculares/mortalidad , Diabetes Mellitus Tipo 2/mortalidad , Neoplasias Endometriales/complicaciones , Neoplasias/mortalidad , Adulto , Anciano de 80 o más Años , Enfermedades Cardiovasculares/complicaciones , Causas de Muerte , Comorbilidad , Complicaciones de la Diabetes/mortalidad , Diabetes Mellitus Tipo 2/complicaciones , Femenino , Humanos , Anamnesis , Neoplasias/complicaciones , Escocia/epidemiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...